DIFMUNIZE

What this means for you

Not registered yet, but its 28 Jun 2022 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.

Record

Serial number

97479415

Mark type

Stylized text

Filed

28 Jun 2022

Published for opposition

18 Apr 2023

Attorney of record

Yana Gorbach

Goods and services

• Class 005 — Pharmaceuticals: Pharmaceutical preparations for the treatment of autoimmune, cardiovascular, central nervous system, endocrine, gastrointestinal, genetic, immunological, infectious, inflammatory, menopausal, metabolic, musculoskeletal, neurodegenerative, neurological, neuromuscular, ophthalmological, psychiatric, respiratory, urogenital, urological and viral diseases and disorders; pharmaceutical preparations for the treatment of blood disorders, liver disorders, erectile dysfunction, sexual dysfunction, cancer, pain and diabetes; pharmaceutical preparations, namely, antifungal preparations, dermatological preparations and smoking cessation preparations; vaccines for human use

Owner

• Pfizer Inc., New York, NY, US
• Pfizer Inc., New York, NY, US

Prosecution history

• 30 Jan 2026 — TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
• 30 Jan 2026 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
• 30 Jan 2026 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
• 30 Jan 2026 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
• 30 Oct 2025 — TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
• 30 Oct 2025 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
• 30 Oct 2025 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
• 30 Oct 2025 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
• 31 Oct 2025 — SOU TEAS EXTENSION RECEIVED
• 20 May 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
• 19 May 2025 — SOU EXTENSION 4 GRANTED
• 19 May 2025 — SOU EXTENSION 4 FILED
• 19 May 2025 — SOU TEAS EXTENSION RECEIVED
• 06 Nov 2024 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
• 06 Nov 2024 — SOU EXTENSION 3 GRANTED